EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer. [electronic resource]
Producer: 20121210Description: 248-56 p. digitalISSN:- 1423-0232
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Asian People -- genetics
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- China
- Chromatography, High Pressure Liquid
- Disease-Free Survival
- ErbB Receptors -- genetics
- Female
- Gene Rearrangement
- Genotype
- Humans
- Immunohistochemistry
- In Situ Hybridization, Fluorescence
- Kaplan-Meier Estimate
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Neoplasm Staging
- Oncogene Proteins, Fusion -- genetics
- Platinum Compounds -- administration & dosage
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.